Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
22.27
-0.87 (-3.76%)
Aug 12, 2026, 3:51 PM EDT - Market open
Caris Life Sciences Market Cap
Caris Life Sciences has a market cap or net worth of $6.29 billion as of August 12, 2026. Its market cap has decreased by -25.05% in one year.
Market Cap
6.29B
Enterprise Value
5.95B
1-Year Change
-25.05%
Ranking
Category
Stock Price
$22.27
ChartMarket Cap Chart
Since the IPO on June 18, 2025, Caris Life Sciences's market cap has increased from $5.95B to $6.29B, an increase of 5.69%. That is a compound annual growth rate of 4.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 6.29B | -17.33% |
| Dec 31, 2025 | 7.61B | 27.84% |
| Jun 18, 2025 | 5.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TG Therapeutics | 7.08B |
| Belite Bio | 6.99B |
| Oruka Therapeutics | 6.93B |
| CG Oncology | 6.83B |
| Cogent Biosciences | 6.72B |
| Mirum Pharmaceuticals | 6.38B |
| Erasca | 6.36B |
| Scholar Rock Holding | 6.34B |